Skip to main content
Premium Trial:

Request an Annual Quote

US to Share More Vaccines

President Joe Biden says the US will provide millions of additional SARS-CoV-2 vaccine doses to other countries, CNN reports.

It adds that the US has already committed to sharing 60 million doses of the AstraZeneca vaccine, which is not yet authorized for use in the US, and now plans to share a further 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines.

"We need to help fight the disease around the world to keep us safe here at home and to do the right thing helping other people. It's the right thing to do, it's the smart thing to do, it's the strong thing to do," President Biden said.

NPR adds that the US will work with COVAX to ensure that the vaccines are fairly distributed.

According to CNN, Biden noted that the US will have enough vaccine supply for every US adult by the end of this month and that the Centers for Disease Control and Prevention says about 60 percent of US adults have received at least one vaccine dose.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.